Table 5.
Odds Ratio (95% CI) | p-value | |
---|---|---|
Age | 0.987 (0.956–1.1018) | 0.987 |
Sex | 0.756 (0.280–2.043) | 0.581 |
Duration of dupilumab use | 1.002 (1.000–1.004) | 0.017 |
AD | 1.739 (0.481–6.295) | 0.399 |
BA | 2.376 (0.520–10.864) | 0.264 |
CRSwNPs | 0.545 (0.193–1.538) | 0.252 |
Syringe | 0.550 (0.128–2.370) | 0.422 |
Pen | 0.398 (0.084–1.892) | 0.247 |
Abbreviations: CI, confidence interval; AD, atopic dermatitis; BA, bronchial asthma; CRSwNPs, chronic rhinosinusitis with nasal polyps.